Literature DB >> 20535851

The consequences for live kidney donors with preexisting glucose intolerance without diabetic complication: analysis at a single Japanese center.

Masahiko Okamoto1, Tomoyuki Suzuki, Masato Fujiki, Shuji Nobori, Hidetaka Ushigome, Seisuke Sakamoto, Norio Yoshimura.   

Abstract

BACKGROUND: Because of lack of deceased donors in Japan, there has been a need to expand the eligibility criteria for live kidney donation. To assess the indications for live kidney donation in glucose intolerance (GI), we analyzed perioperative complications associated with donor nephrectomies performed at our institution and followed up the long-term consequences.
METHODS: The 444 live kidney donors were divided into two groups based on the results of the 75-g oral glucose tolerance test: a GI group (n=71) who showed a diabetic (n=27) or impaired glucose tolerance (n=44) pattern, and a non-GI group (n=373) who showed a normal oral glucose tolerance test pattern. Perioperative complications, longterm survival rate, and frequencies of hypertension, diabetes, hyperlipidemia, and renal dysfunction in long term were compared in each group.
RESULTS: The incidence of perioperative complications was not higher in the GI group than in the non-GI group (4.3% vs. 5.4%, respectively; NS). Survival rates in the GI group at 5, 10, and 20 years were 98.3%, 95.1%, and 89.2%, respectively, whereas those in the non-GI group were 98.0%, 96.1%, and 91.5%, thus showing equivalent mortality. None of the patients in the diabetes mellitus group had developed severe diabetic complications or end-stage renal disease at a mean follow-up point of 88+/-71 (range, 14-225) months.
CONCLUSIONS: Our results suggest that individuals who have GI without diabetic complication may be able to donate their kidney safely with little surgical complication and little major morbidity if strict evaluation is performed before transplant.

Entities:  

Mesh:

Year:  2010        PMID: 20535851     DOI: 10.1097/tp.0b013e3181d9e17b

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Kidney function, albuminuria and cardiovascular risk factors in post-operative living kidney donors: a single-center, cross-sectional study.

Authors:  Masahiko Yazawa; Ryo Kido; Yugo Shibagaki; Takashi Yasuda; Ryuto Nakazawa; Hideo Sasaki; Yuichi Sato; Tatsuya Chikaraishi; Kenjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2011-04-19       Impact factor: 2.801

Review 2.  Long-term medical risks to the living kidney donor.

Authors:  Ngan N Lam; Krista L Lentine; Andrew S Levey; Bertram L Kasiske; Amit X Garg
Journal:  Nat Rev Nephrol       Date:  2015-05-05       Impact factor: 28.314

3.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

4.  Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors.

Authors:  Hassan N Ibrahim; Dina N Murad; Sean A Hebert; Horacio E Adrogue; Hana Nguyen; Duc T Nguyen; Arthur J Matas; Edward A Graviss
Journal:  J Am Soc Nephrol       Date:  2021-10-21       Impact factor: 10.121

5.  A prospective controlled study of kidney donors: baseline and 6-month follow-up.

Authors:  Bertram L Kasiske; Teresa Anderson-Haag; Hassan N Ibrahim; Todd E Pesavento; Matthew R Weir; Joseph M Nogueira; Fernando G Cosio; Edward S Kraus; Hamid H Rabb; Roberto S Kalil; Andrew A Posselt; Paul L Kimmel; Michael W Steffes
Journal:  Am J Kidney Dis       Date:  2013-03-22       Impact factor: 8.860

6.  The Outcomes of Living Kidney Donation from Medically Complex Donors: Implications for the Donor and the Recipient.

Authors:  Matthew Niemi; Didier A Mandelbrot
Journal:  Curr Transplant Rep       Date:  2014-03-01

7.  Clinical efficacy and safety of pamidronate therapy on bone mass density in early post-renal transplant period: a meta-analysis of randomized controlled trials.

Authors:  Zijie Wang; Zhijian Han; Jun Tao; Pei Lu; Xuzhong Liu; Jun Wang; Bian Wu; Zhengkai Huang; Changjun Yin; Ruoyun Tan; Min Gu
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

8.  Preoperative Comorbidities and Outcomes of Medically Complex Living Kidney Donors.

Authors:  Takahisa Hiramitsu; Toshihide Tomosugi; Kenta Futamura; Manabu Okada; Makoto Tsujita; Norihiko Goto; Toshihiro Ichimori; Shunji Narumi; Asami Takeda; Yoshihiko Watarai
Journal:  Kidney Int Rep       Date:  2019-10-10

9.  Long-term impact of baseline serum uric acid levels on living kidney donors: a retrospective study.

Authors:  Kosuke Tanaka; Shigeyoshi Yamanaga; Yuji Hidaka; Sho Nishida; Kohei Kinoshita; Akari Kaba; Toshinori Ishizuka; Satoshi Hamanoue; Kenji Okumura; Chiaki Kawabata; Mariko Toyoda; Akira Miyata; Masayuki Kashima; Hiroshi Yokomizo
Journal:  BMC Nephrol       Date:  2021-03-12       Impact factor: 2.388

Review 10.  Long-term outcomes of kidney donors.

Authors:  Benjamin R Morgan; Hassan N Ibrahim
Journal:  Arab J Urol       Date:  2011-08-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.